Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat add-on therapy in severe persistent asthma
2008-001414-25Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and severe asthma comparing Tiotropium add-on with Placebo add-on (2 arms). Primary endpoints: Peak FEV1 within 3 hours post-dosing and Trough FEV1. Started May 2008; status: completed.
02
Drugs
tiotropium
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2008-001414-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001414-25.